Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease

M. Walker (Vancouver, Canada)

Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Session: PG11 - Translation of animal models to human airway disease
Session type: Postgraduate Course
Number: 136
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Walker (Vancouver, Canada). Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease. Annual Congress 2007 - PG11 - Translation of animal models to human airway disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018



Lung function trajectory research: historical perspective and future prospects
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021



The microbiome in respiratory medicine: current challenges and future perspectives
Source: Eur Respir J , 49 (4)  1602086; DOI: 10.1183/13993003.02086-2016
Year: 2017



Identification of lung transplant candidates, stratification of risk, lung allocation and quality control in Europe using real-time decision-making and big data: lessons learned and future perspectives
Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Year: 2021


Assessment methods in respiratory medicine training in Europe: current status and future needs
Source: Breathe, 16 (1) 190314; 10.1183/20734735.0314-2019
Year: 2020



New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Lessons from behavioral medicine: improving patients function beyond the rehabilitation programme
Source: Annual Congress 2009 - PG20 State of the art in pulmonary rehabilitation
Year: 2009


Exploring new frontiers: the role of simulation as an educational strategy
Source: Breathe 2013; 9: 497-501
Year: 2013

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Impact of continuous medical education (CME) training on improving diagnostic and therapeutic approach to respiratory infections: results of the MATerA project
Source: Eur Respir J 2004; 24: Suppl. 48, 86s
Year: 2004

Introduction: CPET in clinical practice. Recent advances, current challenges and future directions
Source: Eur Respir Monogr 2018; 80: x-xxv
Year: 2018

Lessons from negative dyspnoea studies: arguments for the multidimensional evaluation of multidirectional therapeutic approaches
Source: Eur Respir J, 53 (1) 1802471; 10.1183/13993003.02471-2018
Year: 2019



Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions
Source: Eur Respir J 2016; 48: 1545-1548
Year: 2016


Current insights and potential benefits for effective teaching and learning in respiratory medicine
Source: Breathe 2012; 9: 15-24
Year: 2012

Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021


Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


The era of research collaborations: new models for working together
Source: Eur Respir J 2017; 49(1): 1601848; DOI: 10.1183/13993003.01848-2016
Year: 2017